期刊文献+

Zebularine对K562细胞的增殖及凋亡的影响

Effect of Zebularine on the Proliferation and Apoptosis of K562 Cells
下载PDF
导出
摘要 【目的】探讨药物zebularine对白血病细胞株K562增殖及凋亡的影响。【方法】选择白血病细胞株K562,试验分为对照组(未加入zebularine组)、实验组(zebularine终浓度分别为250,aM,500/tM)组3个组。MTT试剂盒检测12h、24h、36h、48h和72h后K562细胞株OD570;用AnnexinV/FiTC试剂盒与细胞周期检测试剂盒检测k562细胞在药物干预48h后的细胞凋亡情况。【结果】k562细胞株在zebularine干预48h后,随着zebularine处理浓度的增加,细胞活性明显降低(P〈0.01);K562细胞株在zebularine干预48h后,药物浓度250弘M、500pM组与对照组相比,早期凋亡细胞比例与细胞凋亡峰(APO峰)值明显增大,差异有显著性(P〈0.01),500pM组与250uM组相比,早期凋亡细胞比例与细胞凋亡峰(APO峰)值明显增大,差异有显著性(P〈0.01)。【结论】Zebularine可抑制K562细胞株的增殖,促进其凋亡,并有一定的浓度依赖性。 [Obiective] To understand the effect of zebularine on the proliferation and apoptosis of leukemia cells K562 and explore its tumor suppressor mechanism and value in the treatment of leukemia. [Methods] The K562 leukemia cells were selected and divided into the control group(without zebulaine) and the experimental groups(zebularine with the final concentration of 250μM and 500μM, respectively). MTT assay kit was used to detect the OD570 of K562 cells after 12h, 36h, 24h, 48h and 72h. Annexin V/FITC kit and cell cycle kit were used to detect the apoptosis of K562 cells at 48h after drug intervention. [Results] At 48h after drug intervention, the activity of k562 markedly reduced with the increasing of concentration of zebularine( P 〈0.01). Compared with the control group, the proportion of early apoptotic cells and apoptotic peak(APO) value in the experimental groups after 48h of drug intervention increased obviously, but there was significant difference( P 〈0.01). Compared with 250μM group, the proportion of early apoptotic cells and APO peak value of 500μM group increased obviously, and there was significant difference between two groups ( P 〈0.01). [Conclusion]Zebularine can inhibit the proliferation of K562 cells and promote the apoptosis in a dosedependent manner.
出处 《医学临床研究》 CAS 2011年第7期1242-1245,共4页 Journal of Clinical Research
基金 长沙市科技计划项目社会发展科技支撑资金专项(K09050151-31)
关键词 K562细胞 细胞分裂 脱噬作用 K562 cells cell division apoptosis
  • 相关文献

参考文献7

  • 1李培坤,耿小平,朱立新.DNA甲基化抑制剂研究进展[J].国际药学研究杂志,2010,37(3):198-202. 被引量:17
  • 2寿倍明,陈宝安,刘德龙.去甲基化在白血病上的研究进展[J].中国实验血液学杂志,2008,16(5):1247-1250. 被引量:11
  • 3Scott SA,Lakshimikuttysamma A,Sheridan DP,et al.Zebularine inhibits human acute myeloid leukemia cell growth in vitro in association with p15INK4B demethylation and reexpression[J].Exp Hematol,2007,35(2):263-273.
  • 4Marquezy VE,Barchi JJ Jr,Kelley JA,et al.Zebularine:a unique molecule for an epigenetically based strategy in cancer chemotherapy.Themagic of its chemistry and biology[J].Nucleosides Nucleotides Nucleic Acids,2005,24(5-7):305.
  • 5Ben-Kasus T,Ben-Zvi Z,Marquezv E,et al.Metabolic activation of zebularine,a novel DNA methylation inhibitor,in human bladder carcinoma cells[J].Biochem Pharmacol,2005,70(1):121-133.
  • 6Marquez VE,Ben-Kasus T,Barchi JJ Jr,et al.Experimental and structural evidence thatherpes1 kinase and cellula DNA polymerase(s) discriminate on the basisof sugarpucker[J].J Am Chem Soc,2004,126(2):543-549.
  • 7Cheng JC,Yoo CB,Weisenberer DJ,et al.Preferential response of cancer cells to zebularine[J].Cancer Cell,2004,6(2):151-158.

二级参考文献22

  • 1张嘉玲,苏秀兰.去甲基化在肿瘤治疗中的作用[J].中国误诊学杂志,2006,6(23):4531-4533. 被引量:6
  • 2叶雪石,刘霆,崔旭,孟文彤,席亚明.骨髓增生异常综合征P15^(INK4B)基因甲基化及药物去甲基化作用[J].四川大学学报(医学版),2007,38(1):57-59. 被引量:9
  • 3Kanai Y,Hirohashi S. Alterations of DNA methylation associated with abnormalities of DNA methyltransferases in human cancers during transition from a precancerous to a malignant state. Carcinogenesis, 2007 ;28:2434 - 2442
  • 4Lomberk G. Epigenefics. Pancreatology, 2007 25 ;7:396 - 397
  • 5Alien A. Epigenetic alterations and cancer: new targets for therapy. Drugs, 2007; 10:709 -712
  • 6Ray JS, Harbison ML, McClain RaM, et al. Alterations in the mcthylation status and expression of the raf oncogene in pheno- barbital-induced and spontaneous B6C3F1 mouse live tumors. Mol Carcinog, 1994 ;9:155 - 166
  • 7Matsuda Y, Ichida T, Matsuzawa J, et al. p16 (INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma. Gastroenterology, 1999 ; 116:394 -400
  • 8Melki JR, Vincent PC, Clark SJ. Concurrent DNA hyperme- thylation of multiple genes in acute myeloid leukemia. Cancer Res, 1999 ;59:3730 - 3740
  • 9Shen L, Watedand RA. Methods of DNA methylation analysis. Curt Opin Clin Nutr Metab Care, 2007;10:576 -581
  • 10Das PM, Singal R. DNA methylation and cancer. J Clin Oneol, 2004 ; 22 : 4632 - 4642

共引文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部